Publicacions
-
Labad J, Martorell L, Huerta-Ramos ME, Cobo J, Vilella E, Rubio E, Garcia-Pares G, Creus M, Nuñez C, Ortega L, Miquel E, RALOPSYCAT Group and Usall J.
Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 26(10): 1683-1689. Nº de cites: 18
-
Rubio E, Usall J, Barajas A, Carlson J, Iniesta R, Huerta-Ramos ME, Baños I, Dolz M, Sánchez B and Ochoa S.
Relationship between menarche and psychosis onset in women with first episode of psychosis
EARLY INTERVENTION IN PSYCHIATRY . 10(5): 419-425. Nº de cites: 3
-
Rubio-Valera M, Huerta-Ramos ME, Baladon L, Aznar-Lou I, Ortiz JM, Luciano JV, Roset-Arisso PN, Salvador-Carulla L, Villagrán JM, Mayoral F, Gracia A and Serrano-Blanco A.
Qualitative study of the agitation states and their characterization, and the interventions used to attend them
ACTAS ESPANOLAS DE PSIQUIATRIA . 44(5): 166-177. Nº de cites: 10
-
Grau N, Rubio E, Usall J, Barajas A, Butjosa A, Dolz M, Baños I, Sánchez Fernández B, Rodríguez MJ, Peláez T, Sammut S, Carlson J, Huerta-Ramos ME, GENIPE Group and Ochoa S.
Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis
PSYCHIATRY RESEARCH . 242: 157-162. Nº de cites: 19
-
Nuñez C, Ochoa S, Huerta-Ramos ME, Baños I, Barajas A, Dolz M, Sánchez Fernández B, del Cacho N, GENIPE Group and Usall J.
Differential effects of sex on substance use between first episode psychosis patients and healthy people
COMPREHENSIVE PSYCHIATRY . 69: 169-178. Nº de cites: 12
-
Farreny A, Aguado J, Corbera S, Ochoa S, Huerta-Ramos ME and Usall J.
Baseline Predictors for Success Following Strategy-Based Cognitive Remediation Group Training in Schizophrenia
JOURNAL OF NERVOUS AND MENTAL DISEASE . 204(8): 585-589. Nº de cites: 15
-
Huerta-Ramos ME, Escobar-Villegas MS, Rubinstein K, Unoka ZS, Grasa E, Hospedales M, Jääskeläinen E, Rubio E, Caspi A, Bitter I, Berdun J, Seppälä J, Ochoa S, Fazekas K, M-RESIST Group, Corripio I and Usall J.
Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study
JMIR mHealth and uHealth . 4(3): . Nº de cites: 17
-
Usall J, Huerta-Ramos ME, Labad J, Cobo J, Nuñez C, Creus M, Parés GG, Cuadras-Palleja D, Franco J, Miquel E, Reyes JC, Roca M and RALOPSYCAT Group.
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial
SCHIZOPHRENIA BULLETIN . 42(2): 309-317. Nº de cites: 49
-
Nuñez C, Ochoa S, Huerta-Ramos ME, Baños I, Barajas A, Dolz M, Sánchez B, del Cacho N, GENIPE Group and Usall J.
Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use
Psychopharmacology . 233(5): 809-821. Nº de cites: 19
-
Nuñez C, Stephan-Otto C, Cuevas-Esteban J, Haro JM, Huerta-Ramos ME, Ochoa S, Usall J and Brebion G.
Effects of caffeine intake and smoking on neurocognition in schizophrenia
PSYCHIATRY RESEARCH . 230(3): 924-931. Nº de cites: 18